BASKING RIDGE, N.J., April 25, 2016 /PRNewswire/ -- Reproductive Medicine Associates of New Jersey ("RMANJ"), a world-renowned leader in the field of infertility, today released a new Trends in Infertility 2016 Survey and Report, to coincide with National Infertility Awareness Week taking place from April 24-30. The report examines topics in the news including Zika virus as well as trends regarding infertility and assisted reproductive technology (ART) across the U.S.
When it comes to fertility issues, getting the information at the right time is critical and many women are uninformed. RMANJ's Trends in Infertility 2016 Survey and Report revealed that only one quarter (26%) of women have had conversations with their OB/GYNs about their fertility and nearly half (42%) of women who have actually experienced infertility issues reported that their OB/GYN never even started this conversation with them.
"Speaking to a reproductive specialist sooner than later can have a big impact on success for many patients. With new fertility breakthroughs and treatment paradigms unfolding, it's important that patients are equipped with the latest information and resources they need to make good decisions about their care," said Richard Scott, MD, FACOG, ALD/HCLD, laboratory director and a founding partner at RMANJ.
Our survey showed that respondents knew there is a timeline when dealing with fertility, but 57 percent believed that a woman's biological clock stops at age 44. While this is a common misconception, a woman's fertility peaks in her twenties and declines rapidly in her mid to late thirties.
The report also highlighted a major misconception among individuals seeking out fertility care. They are not making the critical distinction between achieving a pregnancy and having a healthy full term delivery. Respondents reported pregnancy rates (35%) as being more important than delivery rates (22%). The goal of fertility treatment should be a happy, healthy baby and patients should always look for delivery rates and reference organizations such as the Society for Assisted Reproductive Technology (SART) who publishes these rates annually.
Another point uncovered in the survey was that 80 percent of respondents (n=800) still believe the transfer of multiple embryos during IVF is required to maximize chance for success. Data published in 2013, reported a 61 percent singleton delivery rate, a lower preterm delivery rate, lower miscarriage and higher birth weight when comprehensive chromosome screening was used in conjunction with single embryo transfer to select the single best embryo for IVF transfer.
Our survey also revealed that respondents are aware of current trends in reproduction. Regarding Zika virus, which is driving headlines around the world, 40 percent of respondents are delaying pregnancy for fear of the impact Zika virus will have. With more media attention to advances in assisted reproductive technology, a majority of respondents, if using IVF, were willing to have embryos genetically tested.
"RMANJ's Trends in Infertility 2016 Survey and Report takes a step at understanding how and where conversations around fertility are taking place and highlights where education is needed for individuals to make informed decisions about their family planning," said Barbara Collura, President/CEO of RESOLVE: The National Infertility Association.
The survey was conducted among 1,000 nationally representative U.S. adults ages 18-40 between March 4 and March 11, 2016, using an email invitation and an online survey. Quotas were set to ensure reliable and accurate representation of U.S. adults ages 18-40.
The full report and infographic RMANJ published depicting the survey results can be found here.
ABOUT REPRODUCTIVE MEDICINE ASSOCIATES OF NEW JERSEY
The experts at RMANJ offer IVF delivery rates of 63.2% percent in women under 35 (n=886) and well above the US average*. Since 1999, they have helped bring nearly 40,000 babies to loving families. RMANJ has 22 physicians and nine locations in New Jersey: Basking Ridge, Eatontown, Englewood, Freehold, Hamilton, Morristown, Short Hills, Somerset, West Orange, and a new 10th location in Marlton, NJ opening in July 2016. For more information, please call 973-656-2089 or visit www.rmanj.com.
RMANJ pioneered and successfully implemented a cutting-edge technology known as Select Comprehensive Chromosome Screening (SelectCCS) to more accurately detect healthy embryos that has led to successful pregnancies and ultimately healthy babies. SelectCCS is owned and operated by the Foundation for Embryonic Competence (www.feclabs.org), and offers advanced embryo selection with extreme accuracy by detecting and avoiding use of embryos with chromosomal abnormalities prior to transfer and pregnancy.
*SART 2014; Cumulative Outcome per Intended Retrieval; Preliminary Chance of Live Birth per Cycle. Please note: A comparison of clinic success rates may not be meaningful because a patient's medical characteristics, treatment approaches and entrance criteria for assisted reproductive technology (ART) may vary from clinic to clinic. Visit www.sart.org to learn more.